Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 EUR | -1.12% | -0.37% | +10.83% |
Apr. 05 | Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors | CI |
Mar. 22 | Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition | MT |
Sales 2023 | 3.91M 4.24M | Sales 2024 * | 5.7M 6.19M | Capitalization | 54.1M 58.79M |
---|---|---|---|---|---|
Net income 2023 | -3M -3.26M | Net income 2024 * | -3M -3.26M | EV / Sales 2023 | 13.8 x |
Net cash position 2023 * | 5.8M 6.3M | Net cash position 2024 * | 1.5M 1.63M | EV / Sales 2024 * | 9.23 x |
P/E ratio 2023 |
-14
x | P/E ratio 2024 * |
-16.6
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 64.06% |
1 day | -1.12% | ||
1 week | -0.37% | ||
Current month | +2.70% | ||
1 month | -3.27% | ||
3 months | +13.68% | ||
6 months | +14.16% | ||
Current year | +10.83% |
Managers | Title | Age | Since |
---|---|---|---|
Timo Lehtonen
CEO | Chief Executive Officer | 49 | 19-02-28 |
Director of Finance/CFO | 57 | 21-01-31 | |
Chairman | 53 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 53 | 16-04-30 | |
Director/Board Member | 50 | 19-12-31 | |
Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.66 | -1.12% | 9,477 |
24-05-16 | 2.69 | -1.10% | 37,129 |
24-05-15 | 2.72 | +1.12% | 22,985 |
24-05-14 | 2.69 | +1.51% | 22,687 |
24-05-13 | 2.65 | -0.75% | 22,521 |
Delayed Quote Nasdaq Helsinki, May 17, 2024 at 11:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.83% | 58.81M | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+5.88% | 6.59B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
-29.53% | 2.66B | |
+47.29% | 2.37B |
- Stock Market
- Equities
- BRETEC Stock